WMSA
AKYA

Weiss Multi-Strategy Advisers’s Akoya BioSciences AKYA Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-50,997
Closed -$249K – 13
2023
Q4 		$249K Sell
50,997
-9,003
-15% -$37.4K 0.01% 502
2023
Q3 		$279K Sell
60,000
-2,836
-5% -$16.3K 0.01% 508
2023
Q2 		$464K Buy
62,836
+52,836
+528% +$353K 0.01% 580
2023
Q1 		$82K Buy
+10,000
New +$104K ﹤0.01% 595

Other funds holding AKYA

BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Weiss Multi-Strategy Advisers's AKYA Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Akoya BioSciences (AKYA) in Q1 2024, closing a stake of 50,997 shares — an estimated $249K sold.

Weiss Multi-Strategy Advisers first reported a position in AKYA in Q1 2023 and held it in 4 quarters. The position peaked at $464K in Q2 2023. 68 funds tracked by Wall St. Rank hold AKYA as of Q1 2024.

  • Weiss Multi-Strategy Advisers reported no remaining Akoya BioSciences position as of Q1 2024 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 50,997 Akoya BioSciences shares in Q1 2024, an estimated $249K.
  • Weiss Multi-Strategy Advisers first reported a position in Akoya BioSciences in Q1 2023 and held it in 4 quarters.
  • Weiss Multi-Strategy Advisers's Akoya BioSciences position peaked at $464K in Q2 2023.
  • 68 funds tracked by Wall St. Rank held Akoya BioSciences as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.